Yesterday, PFE presented data at ICAAC for its HIV NNRTI called UK-453,061, which is in phase-2 and is a direct competitor to IDX-899. See slides #38-41 in <A HREF="http://media.pfizer.com/files/investors/presentations/icaac_2007_presentation_071807.pdf" target="_blank">http://media.pfizer.com/files/investors/presentations/icaac_2007_presentation_071807.pdf</A>